BIOTIME INC 4
4 · BIOTIME INC · Filed Nov 23, 2010
Insider Transaction Report
Form 4
BIOTIME INCBTX
SEGALL JUDITH
DirectorVice President & Secretary
Transactions
- Sale
Common Shares, no par value
2010-11-22$7.52/sh−17,400$130,888→ 522,543 total - Sale
Common Shares, no par value
2010-11-19$7.47/sh−7,600$56,795→ 539,943 total - Sale
Common Shares, no par value
2010-11-23$7.70/sh−2,128$16,380→ 520,415 total
Holdings
- 80,000
Option to Purchase Common Shares
Exercise: $0.32From: 2006-11-24Exp: 2011-11-23→ Common Shares (80,000 underlying)
Footnotes (4)
- [F1]The price of $7.4730 per share represents a weighted average of sales prices ranging from $7.45 to $7.4950 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- [F2]Includes 23,750 shares acquired through a warrant exercise at $1.818 per share on August 18, 2010; 21,586 shares acquired through a warrant exercise at $2.00 per share on November 1, 2010; and 125,000 shares acquired through an option exercise at $2.00 per share on November 5, 2010. Does not include shares that may be acquired upon the exercise of certain stock options.
- [F3]The price of $7.5223 per share represents a weighted average of sales prices ranging from $7.4592 to $7.57 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- [F4]The price of $7.6976 per share represents a weighted average of sales prices ranging from $7.68 to $7.72 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.